Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $312.32 | $7.11 | 4,292.16% | 6,246.40x | 219.77x | 6.92x | 8.38x | 16.83x | $529.27M | 1.54% | $4.13B | 37.48 | $32.46B | 102.08 | ||
| CORT | CORCEPT THERAPEUTICS INC | $81.99 | $26.92 | 204.60% | 81.99x | 82.87x | 11.45x | 13.65x | 1.42x | $162.57M | 1.91% | $631.90M | 6.10 | $8.51B | 128.92 | ||
| NVO | NOVO NORDISK A S | $51.61 | $138.03 | -62.61% | 14.35x | 2.18x | 4.72x | 8.76x | 0.16x | $9.34B | 4.07% | $26.18B | 5.89 | $239.98B | 9.67 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $398.70 | $29.96 | 1,230.79% | 1,286.13x | 212.96x | 16.33x | 225.20x | 5.20x | $221.36M | 0.42% | $233.89M | 1.78 | $54.40B | 358.05 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.53 | $11.69 | -27.01% | 17.77x | 6.53x | 5.66x | 3.61x | 0.35x | -$23.64M | -4.96% | $133.17M | 2.38 | $488.50M | 7.27 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.52 | $14.87 | 185.99% | 86.78x | 42.61x | 5.31x | 6.02x | 1.30x | $101.73M | 3.20% | $535.38M | 7.17 | $3.06B | 57.07 | ||
| GMAB | GENMAB A | $33.65 | $105.50 | -68.11% | 14.36x | 1.87x | 6.06x | 3.76x | 0.13x | $1.19B | 5.53% | $5.75B | 8.96 | $19.99B | 9.99 | ||
| ARGX | ARGENX SE | $845.95 | $281.14 | 200.90% | 33.81x | 47.22x | 27,288.71x | 7.20x | 2.27x | $467.72M | 0.91% | $7.17B | 117.50 | $49.23B | 60.68 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $197.39 | $65.53 | 201.22% | 85.45x | 26.46x | 15.38x | 4.09x | 1.39x | $30.76M | 0.80% | $950.17M | 48.53 | $4.20B | 40.74 | ||
| VCEL | VERICEL CORP | $37.38 | $6.64 | 462.83% | 143.77x | 136.37x | 7.30x | 5.87x | 2.67x | $20.38M | 1.08% | $321.86M | 6.38 | $1.89B | 64.41 | ||
| TECH | BIO-TECHNE CORP | $59.25 | $16.33 | 262.75% | 118.50x | 29.30x | 7.57x | 4.70x | 1.62x | $224.06M | 2.43% | $1.97B | 12.65 | $9.48B | 42.92 | ||
| RPRX | ROYALTY PHARMA PLC | $39.39 | $42.34 | -6.97% | 22.38x | 8.19x | 7.24x | 2.36x | 0.45x | $2.11B | 12.41% | $9.62B | 22.28 | $30.74B | 29.44 | ||
| KRYS | KRYSTAL BIOTECH INC | $253.36 | $67.69 | 274.30% | 36.72x | 40.55x | 19.66x | 6.46x | 3.34x | $166.02M | 2.26% | $1.14B | 39.30 | $6.96B | 36.03 | ||
| VCYT | VERACYTE INC | $42.92 | $9.25 | 364.06% | 110.05x | 80.92x | 6.82x | 2.70x | 2.25x | $98.21M | 2.91% | $1.26B | 15.98 | $3.12B | 54.67 | ||
| CRMD | CORMEDIX INC | $11.98 | $13.25 | -9.60% | 5.28x | 4.79x | 4.25x | 2.52x | 26.26x | $74.42M | 8.18% | $374.13M | 4.93 | $1.04B | 9.30 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.75 | $1.30 | 34.44% | 25.00x | 69.17x | 2.24x | 2.66x | 0.72x | -$11.69M | -8.40% | $52.91M | 0.67 | $135.27M | 15.25 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.18 | $0.75 | 852.24% | 102.57x | 46.93x | 6.08x | 6.79x | 7.53x | $3.05M | 0.47% | $101.92M | 1.12 | $652.44M | 49.32 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $16.21 | $8.19 | 97.84% | 27.95x | 20.64x | 8.04x | 5.84x | 1.23x | $119.87M | 5.61% | $365.77M | 2.78 | $2.14B | 20.69 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $61.14 | $42.93 | 42.42% | 22.48x | 20.39x | 3.79x | 1.94x | 0.82x | $832.13M | 7.09% | $6.06B | 31.54 | $11.09B | 14.36 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.36 | $75.34 | -9.26% | 13.98x | 10.68x | 6.45x | 15.95x | 0.53x | $602.40M | 7.52% | $503.92M | 4.30 | $9.13B | 10.80 | ||
| EXEL | EXELIXIS INC | $46.61 | $29.91 | 55.86% | 18.95x | 17.39x | 5.47x | 5.78x | 1.09x | $779.77M | 6.23% | $2.16B | 8.05 | $12.30B | 13.26 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $459.21 | $170.24 | 169.74% | 32.09x | 24.57x | 10.01x | 6.73x | 1.92x | $3.34B | 2.84% | $17.32B | 67.76 | $113.41B | 24.32 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.44 | $36.84 | 4.33% | 11.90x | 11.80x | 2.68x | 2.65x | 0.78x | $296.89M | 13.42% | $835.12M | 14.51 | $1.74B | 6.44 | ||
| ADMA | ADMA BIOLOGICS INC | $19.49 | $8.45 | 130.56% | 22.15x | 32.66x | 9.52x | 10.76x | 2.12x | $40.73M | 0.88% | $431.19M | 1.81 | $4.65B | 27.02 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.51 | $3.32 | 96.04% | 24.11x | 35.08x | 4.17x | 7.35x | 1.36x | $21.15M | 4.07% | $70.68M | 0.89 | $458.30M | 20.20 | ||
| MNKD | MANNKIND CORP | $5.93 | $1.43 | 313.33% | 59.30x | 74.50x | 5.80x | -40.87x | 2.54x | $43.39M | 2.38% | -$44.55M | -0.15 | $2.05B | 28.06 | ||
| INCY | INCYTE CORP | $100.91 | $68.08 | 48.23% | 16.71x | 14.46x | 4.10x | 4.26x | 1.12x | $1.20B | 6.06% | $4.65B | 23.77 | $17.39B | 10.34 | ||
| INVA | INNOVIVA INC | $19.51 | $15.37 | 26.92% | 10.32x | 9.11x | 3.47x | 1.44x | 1.60x | $196.54M | 14.59% | $1.01B | 14.63 | $1.24B | 5.77 | ||
| UTHR | UNITED THERAPEUTICS CORP | $510.44 | $199.97 | 155.26% | 17.92x | 18.49x | 7.15x | 3.33x | 5.24x | $1.12B | 5.02% | $6.59B | 150.46 | $20.64B | 11.64 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.23 | $12.24 | 97.97% | 13.54x | 15.05x | 5.14x | 3.24x | 4.64x | $234.54M | 7.90% | $920.25M | 7.51 | $2.29B | 7.07 | ||
| MDXG | MIMEDX GROUP INC | $7.00 | $2.77 | 152.41% | 25.00x | 16.34x | 2.63x | 4.34x | 2.22x | $66.82M | 6.44% | $238.95M | 1.61 | $912.85M | 13.19 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $785.17 | $369.67 | 112.40% | 18.07x | 17.88x | 5.71x | 2.67x | 2.42x | $4.22B | 5.19% | $30.96B | 298.82 | $82.72B | 14.48 | ||
| XOMA | XOMA ROYALTY CORP | $25.49 | $4.79 | 432.20% | 31.47x | 22.93x | 6.57x | 3.59x | 77.73x | -$12.41M | -4.01% | $87.94M | 7.25 | $357.08M | 13.35 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.